COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)		6 Months Ended
	Feb. 09, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Subsidiary, Sale of Stock [Line Items]
Proceeds from issuance of common stock			$ 202,000,000
Deferred underwriting commissions		7,070,000		$ 7,070,000
Underwriting Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Deferred underwriting fees		$ 2,525,000
Deferred underwriting commission per unit		$ 0.35
Deferred underwriting commissions		$ 7,070,000
Underwriting Agreement [Member] | Sponsor [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued, shares, share-based payment arrangement, forfeited		700,000
Over-Allotment Option [Member] | Underwriting Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Over allotment option period		45 days
Maxim IPO shares issued		3,000,000
Proceeds from issuance of common stock		$ 2,000,000
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Maxim IPO shares issued		303,000
Deferred underwriting fees	$ 7,070,000